At present, the most widely studied ICIs is anti-programmed cell death 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1), which can enhance the function of T cells and exert an anti-tumor activity (9). The gene discussed is PDCD1; the disease is neoplasm.